Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
LMA Urology is a medical device company specializing in endo-urology, originally established as a division of LMA International. The company is best known for the StoneBreaker, a portable, handheld intracorporeal lithotripter that uses compressed CO2 to fragment urinary stones during ureteroscopy. Unlike traditional pneumatic lithotripters that require external power or air lines, the StoneBreaker is a self-contained, cordless device designed for ease of use and portability in the operating room. In 2012, LMA Urology was acquired by Teleflex as part of its $276 million acquisition of LMA International. Today, the company operates as a subsidiary of Teleflex, and its technology is a key component of Teleflex's urology and surgical product portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on LMA Urology.